Thomson Medical Group Ltd. · SGX:A50

Thomson Medical — Shareholder Meeting (October 2026)

16 slides from Thomson Medical's shareholder meeting presentation, Oct 30, 2026

  1. Slide 1: 26th Annual General Meeting

    26th Annual General Meeting Singapore Date: Friday, 30 October 2026 Time: 3.00 p.m.

  2. Slide 2: Disclaimer

    Disclaimer ANNOUNCEMENT SHALL NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES OR ELSEWHERE. For the purposes of this disclaimer, this presentation (“Presentation”) shall mean and include the slides herein, the oral p

  3. Slide 3: FY2026 Financial Highlights

    FY2026 Financial Highlights 3

  4. Slide 4: Group Financial Highlights – FY2026

    Group Financial Highlights – FY2026 Profitability Financial Position Cash Flows 6.4% increase in Revenue from Cash position of Interest expenses of S$394.7m in FY2025 to S$113.1m S$49.2m S$420.1m in FY2026 Debt of S$1.1b Net cash outflow of 23.2% increase in EBITDA from S$54.6m in FY2025 to Goodwill

  5. Slide 5: Historical Financial Highlights

    Historical Financial Highlights REVENUE ($mil) EBITDA ($mil) ADJUSTED EBITDA(1) ($mil) YoY YoY YoY  6.4%  23.2%  9.9% 67.3 420.1 54.6 394.7 0.5 82.5 YoY 14.8 75.1 0.5 15.0 101.3  1.7% YoY 14.8 YoY  1.7% 98.4  2.9% 21.4 15.0 14.0 YoY  52.2% YoY 14.0 21.4  52.2% YoY 125.4 - - 105.3  19.0% YoY

  6. Slide 6: Geographical Segments – FY2026

    Geographical Segments – FY2026 Revenue EBITDA (S$ in millions) (S$ in millions) S$98.4m S$101.3m (S$15.7m) S$0.5m (S$22.9m) 25% 24% S$48.5m -23% S$0.5m -42% S$46.8m 89% 69% S$105.3m 27% FY2025 FY2025 FY2026 22% FY2026 $394.7m 30% $420.1m 27% $54.6m S$14.8m $67.3m S$15.0m S$125.4m 48% 46% S$192.9m 26

  7. Slide 7: Business Overview, Updates and Growth Plans

    Business Overview, Updates and Growth Plans 7

  8. Slide 8: Key Businesses

    Key Businesses  One of the largest private providers of healthcare services for women and children in Singapore  36 clinics and centres today compared to 16 in 2010 S$192.9m FY26 Revenue  Multi-disciplinary healthcare company listed on Bursa Malaysia  Operates Thomson Hospital Kota Damansara ("T

  9. Slide 9: Thomson Medical Pte Ltd ("TMPL")

    Thomson Medical Pte Ltd (“TMPL”) Singapore Hospital Operations & Ancillary Services 187 licensed beds(1) 36 clinics & centres Established in 1979, TMPL owns and operates Thomson Medical Centre (“TMC”) and a network of Sembawang specialist medical clinics and facilities providing outpatient women and

  10. Slide 10: TMPL Corporate Highlights

    Thomson Medical Pte Ltd (“TMPL”) Corporate Highlights STRATEGIC COLLABORATION WITH PARTNERS AND INSURERS DEEPENING OUR MULTI-SPECIALTY STRATEGY OUR ACHIEVEMENTS NEW FERTILITY CLINIC AT NOVENA 10

  11. Slide 11: TMC Life Sciences Berhad ("TMCLS")

    TMC Life Sciences Berhad (“TMCLS”) Malaysia Hospital Operations & Ancillary Services 399 licensed beds(1)(2) 4 fertility centres In 2008, TMCLS established Thomson Hospital Kota Damansara (“THKD”). THKD is its flagship multi-disciplinary tertiary care centre equipped with advanced medical technology

  12. Slide 12: TMCLS Corporate Highlights

    TMC Life Sciences Berhad (“TMCLS”) Corporate Highlights INITIATIVES BY THKD THOMSON FERTILITY REBRANDING STRATEGIC PARTNERSHIPS ADVANCING CLINICAL EXCELLENCE AND QUALITY STANDARDS 12

  13. Slide 13: Far East Medical Vietnam Limited ("FEMVN")

    Far East Medical Vietnam Limited (“FEMVN”) Hospital Operations & Ancillary Services Vietnam In 2008, FEMVN established Franco-Vietnamese Hospital (“FV Hospital”). As the first JCI accredited 230 3 hospital in South Vietnam, FV Hospital is known for its international standard of care, commitment to l

  14. Slide 14: FEMVN Corporate Highlights

    Far East Medical Vietnam Limited (“FEMVN”) Corporate Highlights NEW TECHNIQUES AND EQUIPMENT – INCLUDING DA VINCI XI ROBOT STRENGTHENING QUALITY AND CLINICAL EXCELLENCE INTRODUCING SOCAL INSURANCE AT FV 14

  15. Slide 15: TMG Going Forward: Turning Growth into Value

    TMG Going Forward: Turning Growth into Value The long-term strategy set in motion in 2022 is beginning to show through in operating performance. The priority ahead is to deepen the same model in each market and translate scale into stronger performance over time. FY2026: revenue grew across all thre

  16. Slide 16: Thank You!

    THANK YOU! 26th Annual General Meeting Presentation [email protected] 16

Thomson Medical Group — Shareholder Meeting (October 2026) on 6ix